BioPharma Resources

Drug Trial Radar · NCT04706013

Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency

Study of Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency

Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

15

Planned (sponsor's estimate)

Start

Feb 16, 2024

Primary completion

Sep 2027

Study completion Sep 2027

Sponsor

Lead sponsor
MedicureIndustry
Sponsor type
Industry
First posted
Jan 12, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The proposed clinical study is intended to evaluate oral P5P for the treatment of patients confirmed to have Pyridox(am)ine 5'-Phosphate Oxidase (PNPO) deficiency via genetic analysis. There is an unmet clinical need for pharmaceutical grade P5P, as to date none has been made commercially available. Patients will receive pharmaceutical grade P5P according to their normal oral P5P dosing regimen, as previously established by their physicians.

Conditions

  • Pyridox(am)Ine 5'-Phosphate Oxidase Deficiency

Interventions

  • Pyridoxal PhosphateDrug

    Oral tablets 50 mg

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall survival time (time to death), including incidence of death at 12 monthsTime frame: 12 months

Locations

10 sites in 3 countries. Site status is shown where the registry gives one.

  • Children's Hospital of Alabama

    Birmingham, Alabama

  • Lucile Packard Children's Hospital

    Palo Alto, California

  • Children's Hospital Colorado

    Aurora, Colorado

  • Boston Children's Hospital

    Boston, Massachusetts

  • Duke Children's Hospital

    Durham, North Carolina

  • Akron's Children's Hospital

    Akron, Ohio

  • Queensland Children's Hospital

    South Brisbane, Queensland, Australia

  • Klinika Neurologii Rozwojowej Uniwersyteckie Centrum Kliniczne - Szpital Gdańskiego Uniwersytetu Medycznego

    Gdansk, Poland

  • Klinika Neurologii Rozwojowej i Epileptologii Instytut Centrum Zdrowia Matki Polki

    Lodz, Poland

  • Uniwersytecki Szpital Kliniczny Klinika Endokrynologii i Diabetologii Wieku Rozwojowego

    Wroclaw, Poland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.